ATE463562T1 - Lp-pla2-aktivitätstest mit hohem durchsatz - Google Patents

Lp-pla2-aktivitätstest mit hohem durchsatz

Info

Publication number
ATE463562T1
ATE463562T1 AT04753533T AT04753533T ATE463562T1 AT E463562 T1 ATE463562 T1 AT E463562T1 AT 04753533 T AT04753533 T AT 04753533T AT 04753533 T AT04753533 T AT 04753533T AT E463562 T1 ATE463562 T1 AT E463562T1
Authority
AT
Austria
Prior art keywords
throughput
activity assessment
pla2 activity
pla2
assessment
Prior art date
Application number
AT04753533T
Other languages
English (en)
Inventor
Yun-Fu Hu
George Walker
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE463562T1 publication Critical patent/ATE463562T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
  • Color Electrophotography (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT04753533T 2003-05-28 2004-05-27 Lp-pla2-aktivitätstest mit hohem durchsatz ATE463562T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47377703P 2003-05-28 2003-05-28
PCT/US2004/016716 WO2005001416A2 (en) 2003-05-28 2004-05-27 High throughput assay of lp-pla2 activity

Publications (1)

Publication Number Publication Date
ATE463562T1 true ATE463562T1 (de) 2010-04-15

Family

ID=33551459

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04753533T ATE463562T1 (de) 2003-05-28 2004-05-27 Lp-pla2-aktivitätstest mit hohem durchsatz

Country Status (13)

Country Link
US (1) US7531316B2 (de)
EP (2) EP2253702A1 (de)
JP (2) JP4892350B2 (de)
AT (1) ATE463562T1 (de)
CY (1) CY1110138T1 (de)
DE (1) DE602004026439D1 (de)
DK (1) DK1633864T3 (de)
ES (1) ES2341772T3 (de)
HR (1) HRP20100285T1 (de)
PL (1) PL1633864T3 (de)
PT (1) PT1633864E (de)
SI (1) SI1633864T1 (de)
WO (1) WO2005001416A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4892350B2 (ja) 2003-05-28 2012-03-07 グラクソ グループ リミテッド Lp−PLA2活性のハイスループットアッセイ
JP5155564B2 (ja) 2004-02-03 2013-03-06 ディアデクサス インコーポレーテッド Lp−PLA2活性を検出する方法
US20150017671A1 (en) 2004-04-16 2015-01-15 Yaping Shou Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
US7741020B2 (en) 2004-04-16 2010-06-22 Glaxo Group Limited Methods for detecting Lp-PLA2 activity and inhibition of Lp-PLA2 activity
US20140283157A1 (en) 2013-03-15 2014-09-18 Diadexus, Inc. Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
EP3258269B1 (de) * 2015-02-10 2019-06-05 Shenzhen New Industries Biomedical Engineering Co. Ltd. Reagenzienkit für den nachweis von lipoproteinassoziierter phospholipase a2 und herstellungsverfahren sowie anwendung für reagenzienkit
CN104820097A (zh) * 2015-05-22 2015-08-05 北京协和洛克生物技术有限责任公司 一种定量检测样本中脂蛋白磷脂酶a2浓度的液态芯片试剂盒及其制备方法
JP6691212B2 (ja) 2016-06-22 2020-04-28 旭化成ファーマ株式会社 Lp−PLA2活性の測定

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3204681B2 (ja) 1991-05-24 2001-09-04 株式会社シノテスト 新規なエーテル型チオリン脂質化合物およびその製造法
DE69423436T2 (de) * 1993-06-25 2000-09-07 Smithkline Beecham Plc An lipoprotein gebundene phospholipase a2, inhibitoren davon und deren verwendung für diagnose und therapie
JPH0759597A (ja) 1993-08-23 1995-03-07 Shinotesuto:Kk 血小板活性化因子アセチルヒドロラーゼ活性測定方法
US6146625A (en) 1993-10-06 2000-11-14 Icos Corporation Platelet-activating factor acetylhydrolase
ES2159573T3 (es) 1993-10-06 2001-10-16 Icos Corp Acetilhidrolasa del factor activador de plaquetas.
JPH1017600A (ja) 1996-06-28 1998-01-20 Suntory Ltd 血小板活性化因子アセチルヒドロラーゼおよびその遺伝子
JP4220603B2 (ja) 1998-12-02 2009-02-04 アルフレッサファーマ株式会社 血小板活性化因子アセチルヒドロラーゼ活性の測定方法
US20020102231A1 (en) 1999-05-07 2002-08-01 Icos Corporation Therapeutic uses of PAF-AH products in diabetes
FR2815857B1 (fr) 2000-10-30 2003-02-14 Oreal Composition, notamment cosmetique, renfermant un retinoide et une silicone benzotriazole
EP1318154B1 (de) 2001-12-07 2004-06-16 SIRS-Lab GmbH Verbindungen zur Bestimmung der Aktivität von Phospholipase A2
US20030134082A1 (en) * 2001-12-21 2003-07-17 Morin Brian G. Carpet comprising a low-shrink backing of polypropylene tape fibers
US20070077614A1 (en) 2003-04-01 2007-04-05 Wolfert Robert L Uses of lp-pla2 in combination to assess coronary risk
JP4892350B2 (ja) 2003-05-28 2012-03-07 グラクソ グループ リミテッド Lp−PLA2活性のハイスループットアッセイ
JP5155564B2 (ja) 2004-02-03 2013-03-06 ディアデクサス インコーポレーテッド Lp−PLA2活性を検出する方法
US7741020B2 (en) 2004-04-16 2010-06-22 Glaxo Group Limited Methods for detecting Lp-PLA2 activity and inhibition of Lp-PLA2 activity

Also Published As

Publication number Publication date
DE602004026439D1 (de) 2010-05-20
ES2341772T3 (es) 2010-06-28
JP2012050443A (ja) 2012-03-15
WO2005001416A3 (en) 2005-03-17
PT1633864E (pt) 2010-06-24
JP5637959B2 (ja) 2014-12-10
EP2253702A1 (de) 2010-11-24
PL1633864T3 (pl) 2010-09-30
EP1633864B1 (de) 2010-04-07
DK1633864T3 (da) 2010-07-12
JP2007502131A (ja) 2007-02-08
CY1110138T1 (el) 2015-01-14
EP1633864A2 (de) 2006-03-15
HRP20100285T1 (hr) 2010-06-30
JP4892350B2 (ja) 2012-03-07
WO2005001416A2 (en) 2005-01-06
SI1633864T1 (sl) 2010-07-30
EP1633864A4 (de) 2006-06-14
US7531316B2 (en) 2009-05-12
US20070065892A1 (en) 2007-03-22

Similar Documents

Publication Publication Date Title
CY1110138T1 (el) Προσδιορισμος υψηλης διεκπεραιωτικοτητας της δραστικοτητας lp-pla2
IS6316A (is) Aðferð til erfðafræðilegra greininga
DK2620510T4 (da) Enkeltmolekyle-arrays til genetisk og kemisk analyse
DE60209780D1 (de) Vorrichtung für chemische oder biochemische analysen
DE60318642D1 (de) Multi-Test-Analyse von Echzeit-Nukleinsäureamplifikationen
DE602004015886D1 (de) Vorrichtung zur Vorhersage von Kollisionen
DE60309492D1 (de) Arbeitsplatz zur bereitstellung proben
DE602005023517D1 (de) Verfahren zur bestimmung von genotoxizität
IS7992A (is) Dýralaus frumuræktunar aðferð
DK1718967T3 (da) Metoder til at detektere Lp-PLA2 aktivitet
DE602005008146D1 (de) Methode für die Quantifizierung der Ausgangs-Konzentration von Nukleinsäuren ausgehend von real-time Amplifikationsdaten
ATE549416T1 (de) Verfahren und zusammensetzungen zum nachweis von autoimmunkrankheiten
ATE484231T1 (de) Vorrichtung für vorhersage von muskel/skelett- erkrankungen
DE60302814D1 (de) Vorrichtung für eine tierbezogene Handlung
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
DE60302527D1 (de) Messsystem für lebende Körper
DK1456404T3 (da) Fremgangsmåde til at bestemme difibrotids biologiske aktivitet
DE602005018993D1 (de) Vorrichtung zur optischen Aufzeichnung von Informationen
DE502005002108D1 (de) Verfahren zur funktionalisierung von biosensor-chips
DE60211958D1 (de) Schwefelhaltiger automatenstahl
DK1709198T3 (da) Peptidnukleinsyreprober til analyse af visse staphylococcus-arter
DE602004029183D1 (de) Biologische photometrische ausrüstung
DE112006001519A5 (de) Verfahren und Einrichtung zur Ermittlung von Informationen über ein Tier und/oder Tiermilch
NO20043400L (no) Fremgangsmater for nukleinsyreamplifisering
DE602004022472D1 (de) Vorrichtung für Erkennung von Änderungsinformation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1633864

Country of ref document: EP